Blueprint Medicines Corp reports

Company location: Cambridge, MA
Fiscal year end: 31 December

Blueprint Medicines Corp has filed 1,025 SEC EDGAR filings since 17 Jan 2014

Filter by type:
10-K
10-Q
8-K
SC13G

SEC filing history

Showing 376-400 of 1,000 matching filings.

Per page

25

Current page

16

3/A

3/A filing

Filing date: 31 Mar 2022
Reporting date: 08 Dec 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4 filing

Filing date: 23 Mar 2022
Reporting date: 03 Nov 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4 filing

Filing date: 18 Mar 2022
Reporting date: 16 Mar 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4 filing

Filing date: 14 Mar 2022
Reporting date: 10 Mar 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4 filing

Filing date: 08 Mar 2022
Reporting date: 03 Mar 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4 filing

Filing date: 08 Mar 2022
Reporting date: 03 Mar 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4 filing

Filing date: 08 Mar 2022
Reporting date: 07 Mar 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4 filing

Filing date: 08 Mar 2022
Reporting date: 03 Mar 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4 filing

Filing date: 08 Mar 2022
Reporting date: 03 Mar 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4 filing

Filing date: 08 Mar 2022
Reporting date: 03 Mar 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4 filing

Filing date: 08 Mar 2022
Reporting date: 07 Mar 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4 filing

Filing date: 08 Mar 2022
Reporting date: 03 Mar 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4 filing

Filing date: 08 Mar 2022
Reporting date: 03 Mar 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4 filing

Filing date: 08 Mar 2022
Reporting date: 03 Mar 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4 filing

Filing date: 07 Mar 2022
Reporting date: 03 Mar 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4 filing

Filing date: 03 Mar 2022
Reporting date: 01 Mar 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4 filing

Filing date: 03 Mar 2022
Reporting date: 01 Mar 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4 filing

Filing date: 03 Mar 2022
Reporting date: 01 Mar 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4 filing

Filing date: 03 Mar 2022
Reporting date: 01 Mar 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4 filing

Filing date: 03 Mar 2022
Reporting date: 01 Mar 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4 filing

Filing date: 03 Mar 2022
Reporting date: 01 Mar 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4 filing

Filing date: 03 Mar 2022
Reporting date: 01 Mar 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4 filing

Filing date: 03 Mar 2022
Reporting date: 01 Mar 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4 filing

Filing date: 03 Mar 2022
Reporting date: 01 Mar 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4 filing

Filing date: 03 Mar 2022
Reporting date: 01 Mar 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .